Braden Michael Leonard, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 273,730 shares at $1.33 ($359K) on 2024-07-31, disclosed to the SEC on 2024-07-31.
Open-market purchase of $359k ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 173,730 | $226K | 62.9% |
| 2 | $1.33 | 100,000 | $133K | 37.1% |
| Total | $1.31 avg | 273,730 | $359K | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |